Scholar Rock (NASDAQ:SRRK) Sets New 1-Year High – Here’s What Happened

Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) reached a new 52-week high during trading on Wednesday . The stock traded as high as $50.50 and last traded at $49.16, with a volume of 5327282 shares traded. The stock had previously closed at $43.08.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Citigroup boosted their price target on shares of Scholar Rock from $55.00 to $58.00 and gave the stock a “buy” rating in a research note on Wednesday, March 4th. HC Wainwright restated a “buy” rating and issued a $58.00 price objective on shares of Scholar Rock in a research report on Tuesday, March 3rd. BMO Capital Markets lifted their price objective on Scholar Rock from $50.00 to $70.00 and gave the company an “outperform” rating in a report on Wednesday, March 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Scholar Rock in a research note on Thursday, January 22nd. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Scholar Rock in a report on Thursday, December 11th. Four equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Buy” and an average target price of $54.36.

Scholar Rock Stock Performance

The stock’s 50 day moving average price is $45.11 and its two-hundred day moving average price is $40.62. The company has a current ratio of 6.95, a quick ratio of 6.95 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $5.65 billion, a price-to-earnings ratio of -14.33 and a beta of 0.70.

Scholar Rock (NASDAQ:SRRK) last released its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.76) EPS for the quarter, topping analysts’ consensus estimates of ($0.86) by $0.10. During the same quarter in the previous year, the company posted ($0.64) EPS. On average, analysts forecast that Scholar Rock Holding Corporation will post -2.42 EPS for the current year.

Insider Activity at Scholar Rock

In related news, General Counsel Junlin Ho sold 9,580 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $46.53, for a total value of $445,757.40. Following the completion of the transaction, the general counsel directly owned 241,545 shares of the company’s stock, valued at $11,239,088.85. This trade represents a 3.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Caryn Parlavecchio sold 9,035 shares of Scholar Rock stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $46.53, for a total value of $420,398.55. Following the transaction, the insider directly owned 169,087 shares of the company’s stock, valued at approximately $7,867,618.11. This represents a 5.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 207,464 shares of company stock valued at $9,157,423 in the last 90 days. Insiders own 13.30% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in SRRK. Three Seasons Wealth LLC raised its stake in shares of Scholar Rock by 2.1% during the 4th quarter. Three Seasons Wealth LLC now owns 10,968 shares of the company’s stock worth $483,000 after buying an additional 222 shares during the last quarter. IFP Advisors Inc grew its stake in Scholar Rock by 294.1% in the 4th quarter. IFP Advisors Inc now owns 603 shares of the company’s stock valued at $27,000 after acquiring an additional 450 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Scholar Rock by 7.9% during the 3rd quarter. Principal Financial Group Inc. now owns 6,214 shares of the company’s stock valued at $231,000 after acquiring an additional 456 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Scholar Rock by 151.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company’s stock valued at $38,000 after acquiring an additional 525 shares in the last quarter. Finally, California State Teachers Retirement System raised its position in Scholar Rock by 0.9% during the second quarter. California State Teachers Retirement System now owns 62,372 shares of the company’s stock worth $2,209,000 after acquiring an additional 577 shares during the last quarter. Hedge funds and other institutional investors own 91.08% of the company’s stock.

Scholar Rock Company Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).